Marvel Diagnostics News Today

Share: near term COVID-19 vaccination allocations to follow TORONTO, May 17, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve") ((NEO:MEDV, OTC:COPRF, FRA:4NC)) a healthcare technology and services company, today announced it has signed a binding agreement to acquire 100% of all outstanding shares of Marbella, a nonsterile compounded California state licensed and insured pharmacy. This acquisition advances Medivolves growth strategy and expands its ability to deliver patient care through...

Credit: Medivolve  “You’re going to see who the superspreaders are or who potentially might be spreading the virus more than others,” Medivolve CEO David Preiner said. Preiner believes the new technology could be a viable substitute for the traditional nasal swab COVID-19 test and could be used in drive-through testing or within schools. “It makes it very easy to gather samples on a routine basis with no fear of it’s going to hurt,” Preiner explained.  And even as the effects of t...

Article content Medivolve is well positioned to deliver shareholder value from its equity position in Marvel Diagnostics and the team’s successful development of BlowFISH, a non-invasive exhaled breath diagnostic technology that has cleared the first milestone in a series of clinical tests and has entered the next phase toward applying for an Emergency Use Authorization from the FDA to use the technology to test for the COVID-19 virus. TORONTO, May 05, 2021 (GLOBE NEWSWIRE) —  Medivolve I...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Collection Sites Provides Update With January Sales of 73,973 Tests at an Average Price of $96 ... Medivolve Inc.February 4, 2021 GMT To date Collection Sites has launched a total of 62 sites across its network with additional new openings in Texas, Florida, and North Carolina. Further, Medivolve will host a webinar today, Thursday, February 4th at 1 pm ET. TORONTO, Feb. 04, 2021 (GLOBE NEWSWIRE) -- M...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Medivolve Enters Into Agreement to Acquire 100% of Noble Bioscience Corp. and Its Agency Rights ... Medivolve Inc.February 2, 2021 GMT Nuturell’s non-toxic silver surface shield technology is a COVID-19 disinfectant that converts into a protective shield when air dry, killing the coronavirus among other pathogens for up to 90 days after only ~30 seconds of contact. Further, Medivolve will host a web...